Bath & Body Works (BBWI) has opened Q1 2027 with total revenue of US$1.4 billion and basic EPS of US$0.91 on net income of US$183 million, setting the tone for how investors will judge whether the business is holding its ground after a softer stretch of growth. Over recent periods the company has seen quarterly revenue move from US$1.4 billion in Q1 2026 to US$1.6 billion in Q3 2026 and US$2.7 billion in Q4 2026. Basic EPS ranged from US$0.30 to US$2.09 over that span, so this quarter’s results land against a backdrop of already compressed net margins and modest earnings growth expectations.

See our full analysis for Bath & Body Works.

With the latest numbers on the table, the next step is to see how they stack up against the dominant narratives around Bath & Body Works, highlighting where the story holds up and where investors may want to question their assumptions.

Margins Under Gentle Pressure

• On a trailing 12 month basis, Bath & Body Works earned US$727 million of net income on US$7.2b of revenue, which translates to a 10% net margin compared with 11.1% a year earlier.
• Consensus narrative notes that investments in digital platforms and omnichannel are meant to support brand strength and long term earnings. However, the slip in net margin alongside modest forecast revenue growth of about 1.5% a year shows that higher costs for technology, new stores, and tariffs are still weighing on profitability even as those initiatives aim to keep the business competitive and relevant.
  • Rising operating expenses such as SG&A and ongoing tariff impacts, highlighted by the US$85 million tariff forecast for 2025, line up with the margin compression already visible in the 10% trailing margin.
  • The push into wellness focused products and cleaner formulations is expected to support pricing power. The current margin trend suggests it has not yet fully offset these extra cost pressures.

Low P/E Versus Peers

• Bath & Body Works is trading on a P/E of 5.4x based on trailing earnings, compared with around 20.5x for the US Specialty Retail industry and 20.6x for peers, at a share price of US$19.45.
• What stands out for the bullish narrative is that the current P/E is low while a DCF fair value of about US$32.76 per share and an analyst price target reference of US$26.54 both sit above the current price. At the same time, trailing 12 month earnings have declined at about 9.7% per year over five years and expected annual earnings growth of roughly 3.5% remains modest, so the valuation gap is paired with only moderate growth assumptions and known balance sheet risks.
  • Bulls point to recurring demand from classic fragrances and international expansion, but the multi year earnings decline shows that past profitability has not kept pace with those ambitions.
  • The discount relative to both DCF fair value and the analyst target could reflect those slower earnings trends plus concerns about negative shareholders' equity and high debt that are flagged as key risks.

On a valuation this compressed, bulls argue there is a lot already priced in and that even modest execution on growth could matter for long term returns. It can be useful to see how their full case is built from the numbers 🐂 Bath & Body Works Bull Case

Balance Sheet Risk Versus Earnings Quality

• Over the last 12 months Bath & Body Works generated Basic EPS of US$3.55, described as high quality earnings, while at the same time carrying negative shareholders' equity and a high level of debt, with an unstable dividend track record flagged as an added risk.
• Bears argue that the combination of negative equity, leverage, and cost pressures could limit how much value investors ultimately get from these earnings. The data supports some of that caution because the trailing net margin of 10% is already below last year's 11.1% and five year earnings have declined around 9.7% annually. At the same time, the business still produces positive net income and EPS, which means cash generation is present even as the capital structure adds another layer of risk to the story.
  • The bearish view that higher costs for sustainability, marketing, and operations can strain profit is consistent with the modest margin compression already visible in the trailing data.
  • The existence of positive net income of US$727 million on a trailing basis challenges the idea that the core business is fundamentally broken, instead pointing to a tension between earnings quality and the balance sheet profile.

Skeptics warn that strong reported EPS can mask structural balance sheet issues, so checking the full bear case against these margin and leverage figures can help you weigh how much risk you are really taking on 🐻 Bath & Body Works Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Bath & Body Works on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

All of this raises a simple question: are you comfortable with how the risk and reward balance looks here, or not yet? If you want to move quickly and build your own view from the underlying data and forecasts, start with the 2 key rewards and 3 important warning signs.

See What Else Is Out There

Bath & Body Works combines a compressed P/E, modest earnings growth expectations, margin pressure, and balance sheet concerns, which can make the overall risk profile feel uncomfortable.

If you want stocks where the financial footing looks steadier, use the solid balance sheet and fundamentals stocks screener (46 results) to quickly zero in on companies with stronger balance sheets right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.